AZD7507 is primarily investigated for its potential therapeutic applications, particularly in the field of oncology. It is studied as a kinase inhibitor, targeting specific enzymes involved in cancer cell proliferation and survival. The compound shows promise in preclinical studies for inhibiting pathways that drive tumor growth, making it a candidate for treating various cancers. Researchers are exploring its efficacy in combination with other therapies to enhance anti-tumor effects and overcome resistance mechanisms. Additionally, AZD7507 is being evaluated for its safety profile and pharmacokinetics to determine its suitability for clinical trials. Its development underscores the ongoing efforts to discover novel treatments for challenging malignancies.